Skip to content
desvenlafaxine

Structure via PubChem · Public domain (PubChem)

EntityQ2419445· pop 21· linked from 1,617 articles

desvenlafaxine

Sign in to save

Also known as WY-45233, 1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol, O-desmethylvenlafaxine, ODV, (±)-desvenlafaxine

Desvenlafaxine, sold under the brand name Pristiq among others, is a medication used to treat depression. It is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class and is taken by mouth. It is recommended that the need for further treatment be occasionally reassessed. Studies have shown similar effectiveness compared to its parent compound venlafaxine.

Chemical data

Formula
C16H25NO2
Molecular weight
263.37 g/mol
IUPAC name
4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol
SMILES
CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
InChIKey
KYYIDSXMWOZKMP-UHFFFAOYSA-N
XLogP
2.6
Polar surface area
43.7 Ų
H-bond donors
2
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2008
Admin. routes
oral
Indications
fibromyalgia, chronic hepatitis C virus infection, major depressive disorder, depressive disorder

via ChEMBL · EBI

Wikidata facts

Subclass of
medication
Mass
263.188529
Show 9 more facts
chemical formula
C₁₆H₂₅NO₂
defined daily dose
50.0
significant drug interaction
tranylcypromine
canonical SMILES
CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
World Health Organisation international non-proprietary name
desvenlafaxine
medical condition treated
anxiety
Commons category
Desvenlafaxine
legal status (medicine)
boxed warning
Sources (5)

via Wikidata · CC0

~6 min read

Encyclopedic overview

10 sections
Contents
  • Medical uses
  • Adverse effects
  • Pharmacology
  • Approval status
  • United States
  • Canada
  • European Union
  • Australia
  • See also
  • References

Desvenlafaxine, sold under the brand name Pristiq among others, is a medication used to treat depression. It is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class and is taken by mouth. It is recommended that the need for further treatment be occasionally reassessed. Studies have shown similar effectiveness compared to its parent compound venlafaxine.

Common side effects include dizziness, trouble sleeping, increased sweating, constipation, sleepiness, anxiety, and sexual problems. Serious side effects may include suicide in those under the age of 25, serotonin syndrome, bleeding, mania, and high blood pressure. There is a high risk of withdrawal syndrome which may occur if the dose is decreased or the medication is completely stopped. It is unclear if use during pregnancy or breastfeeding is safe.

Excerpted from Wikipedia’s “desvenlafaxine” article, available under the CC BY-SA 4.0 licence.

Gallery (2)